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INTRODUCTION
Actinic cheilitis (AC) is a potentially malignant lesion af-
fecting mainly the lower lip. It is caused by chronic and excessive 
exposure of the lips to ultraviolet radiation, especially UVB. It af-
fects primarily white-skinned men, aged 40-60, whose occupational 
activities involve chronic sun exposure.1,2
Exposure to ultraviolet radiation causes disruption of the 
cell cycle and damage to DNA repair systems. These systems per-
form physiological functions that play a fundamental role in main-
taining normal cell function. The mismatch repair system (MMR) is 
involved in correcting damage. Human mutS homolog 2 (hMSH2) 
and human mutL homolog 1 (hMLH1) are genes that are integrated 
in the MMR system of DNA bases. These genes produce the pro-
teins hMSH2 and hMLH1, which are fundamental for the system. 
The inactivation of one or more MMR genes will not correct the 
mismatched bases, which may cause the destabilization of micro-
satellite sequences in both non-coding and coding portions of the 
genome, resulting in microsatellite instability (MSI).3,4
Changes in immunoexpression of the hMLH1 and hMSH2 
proteins are frequently detected in potentially malignant lesions 
as AC and cancer. In normal tissues, the immunoexpression of the 
hMSH2 and hMLH1 has also been studied and correlated with the 
MMR system’s normal function.5-8
The studies found in the literature associate the immunoex-
pression of hMLH1 and hMSH2 proteins with histologic aspects, but 
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do not correlate it with clinical and epidemiological data.4,5,8	Thus,	
this study aimed to evaluate the immunohistochemical expression 
of	hMLH1	and	hMSH2,	comparing	it with	clinical	aspects	of	AC.	To	
our	knowledge,	 this	 study	 is	 the	first	 to	associate	 the	 immunoex-
pression	of	those	proteins	with	clinical	parameters,	which	is	import-
ant to enhance understanding of these lesions’ behaviour in patients 
with different clinical.
METHODS
Ethical considerations
The study was approved by the Research Ethics Committee 
of	the	Federal	University	of	Rio	Grande	do	Norte	(UFRN)	(CEP⁄U-
FRN-028/2010).
Tissue specimens
We	 analyzed	 40	 blocks	 of	 tissue	 specimens	with	AC,	 ob-
tained	from	the	Laboratory	of	Oral	Pathology,	Department	of	Den-
tistry,	UFRN,	Natal,	Rio	Grande	do	Norte.	The	diagnosis	of	AC	was	
confirmed	 by	 reviewing	 patients’	 histopathological	 and	 clinical	
data.	 The	 following	 inclusion	 criteria	were	 applied:	 1.	AC	with	 a	
white	and/or	 red	clinical	appearance;	2.	 located	on	 the	 lower	 lip.	
The	 clinical	variables	of	gender,	 age,	 ethnicity,	 clinical	 aspect	 and	
occupational	 sunlight	 exposure,	 were	 evaluated.	 The	 immunoex-
pression of hMLH1 and hMSH2 proteins was compared with these 
variables.
Morphological study
For	 histological	 examination,	 5-µm-thick	 sections	 stained	
with	 hematoxylin	 and	 eosin	were	 analyzed.	 To	diagnose	AC,	 ba-
sophilic	changes	 in	the	connective	tissue	were	required	(basophil-
ic	 changes	 are	 characterized	 by	 the	 replacement	 of	 eosinophilic	
collagen	by	an	amorphous	basophilic	granular	material),	not	with	
standing the presence of dysplasia. We adopted the World Health 
Organization	(WHO)	criteria	for	grading	epithelial	dysplasia.	Two	
oral	pathologists,	who	were	unaware	of	the	demographic,	histolog-
ical	and	clinical	characteristics	of	the	sample,	analyzed	the	samples.
Immunohistochemistry
For	 immunohistochemical	 analysis,	 3-µm-thick	 sections	
were mounted on organosilane-coated slides (3-aminopropyl-
triethoxysilane;	Sigma	Chemical	Co.,	St.	Louis,	MO,	USA).	Primary	
mouse monoclonal antibodies against hMLH1 and hMSH2 were 
used.	The	specifications	of	anti-hMLH1	(clone:	G168-15,	Pharmin-
gen	-	San	Diego,	CA,	USA)	were	1:200	dilution,	Tris-EDTA	pH	9.0	
for	antigen	retrieval,	and	18	hours	(Overnight)	 for	 incubation.	The	
specifications	of	anti-hMSH2	(clone:	G219-1129,	Pharmingen	-	San	
Diego,	CA,	USA)	were	1:200	dilution,	no	antigen	retrieval,	and	18	
hours (Overnight)	 for	 incubation.	After	 antigen	 retrieval,	 endoge-
nous	peroxidase	was	blocked	with	a	1:1	solution	of	methanol	and	
3%	hydrogen	peroxide.	Antibodies	were	detected	by	immunoperox-
idase	staining,	using	a	dextran	polymer-based	signal	enhancement	
technique	 (ADVANCETM,	Dako,	Carpinteria,	CA,	USA).	The	 reac-
tion	was	developed	with	diaminobenzidine	as	chromogen.	The	sec-
tions were counterstained with Mayer’s hematoxylin and mounted 
in	Permount®	(Fisher	Scientific,	Fair	Lawn,	NJ,	USA).	Negative	con-
trols consisted of the replacement of the primary antibodies with 
bovine	serum	albumin,	while	samples	of	normal	oral	mucosa	and	
colon	carcinoma	specimen	with	known	positive	reactivity	were	in-
cluded as positive controls.
Quantification of immunostained cells
According	to	Caldeira	et al.5,	evaluation	of	the	whole	epithe-
lium is more relevant than separate analysis of each epithelial layer.5 
Only epithelial cells that exhibited brown nuclear immunoreactivity 
were considered positive.
The specimens were examined under a light microscope 
(Olympus	CH30,	Olympus	Co.,	Tokyo,	Japan)	by	two	properly	cal-
ibrated	 oral	 pathologists,	 in	 a	 blind	 study.	 Initially,	 the	 slide	 area	
with	 the	 largest	number	of	 immunostained	cells	was	 identified	at	
100x	magnification.	Next,	consecutive	fields	of	each	case	were	pho-
tographed	at	400x	magnification	using	the	Infinity	1-3C	camera	(Lu-
menera	Co.,	Ottawa,	Canada),	coupled	to	a	light	microscope	(Nikon	
Eclipse	E200MV,	Nikon,	Tokyo,	Japan).	The	images	were	captured	
using	 the	Lumenera	 Infinity	Analyze	 software,	version	5.0.3.	One	
thousand	cells	were	counted	(positive	and	negative	cells)	using	the	
ImageJ	 program	 (ImageJ	 for	Mac	OS	X,	 version	 1.44,	 64-bit	 Java:	
Wayne	Rasband,	National	Institute	of	Health,	USA).	Using	this	soft-
ware	does	not	affect	interpretation,	since	the	software	is	only	used	to	
mark	the	cells	counted,	not	to	change	the	processed	image.
Data analysis
The	data	were	analyzed	using	the	SPSS	18.0	software	(SPSS,	
Inc.,	Chicago,	IL,	USA).	A	normal	distribution	was	observed,	while	
the Student t-test was used to compare the mean immunoexpres-
sion	 of	 hMLH1	 and	 hMSH2	 between	 clinical	 variables.	A	 signifi-
cance level of 5% was adopted.
RESULTS
We	observed	 that	patients	were	 represented	by	males	 (3:1)	
with	a	mean	age	of	53.5	±	17.04	years.	Sixteen	(40.0%)	cases	showed	
no	 dysplasia,	 though	 mild	 dysplasia	 was	 observed	 in	 10	 (25.0%),	
moderate	dysplasia	in	11	(27.5%)	and	severe	dysplasia	in	3	(7.5%).	The	
immunoexpression of these proteins was higher in women under 40 
and	among	black	and	mixed-race	individuals,	but	without	significant	
differences.	AC	with	a	white-colored	appearance	and	patients	with-
out	occupational	sunlight	exposure,	also	presented	greater	immuno-
expression	of	these	proteins;	no	statistical	differences	were	observed	
for the variables studied. There is a tendency of the expression these 
proteins	 in	actinic	 cheilitis	not	 related	 to	 solar	 factor	 (Table	1).	The	
immunoexpression	images	are	shown	in	figure	1.
DISCUSSION
AC	is	a	potentially	malignant	lesion	on	the	lips	with	a	trend	
for malignant transformation from 10 to 30%.1,5,9	It is more preva-
lent	 among	men,	 caucasians,	with	a	male-to-female	 ratio	of	 2-4:1.	
The	peak	of	prevalence	is	observed	in	patients	aged	over	40.1,9-11	All	
the aforementioned characteristics were noted in this sample. Most 
AC	patients	had	professional	activities	involving	sun	exposure,	con-
firming	AC’s	association	with	ultraviolet	radiation	as	the	main	risk	
factor for this lesion.12,13
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Ultraviolet radiation can cause direct and indirect dam-
age	 to	 DNA	 through	 oxidative	 stress,	 promoting	 mutations	 in	
key	 genes	 linked	 to	 cell	 proliferation,	 DNA	 repair	 and/or	 death	
cells.4,14,15	These changes can be corrected by the MMR system. MMR 
proteins	(hMLH1	and	hMSH2)	are	important	for	maintaining	gene	
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stability,	participating	in	cell	cycle	arrest,	correcting	errors	in	replica-
tion,	whilst	stimulating	programmed	cell	death	in	cases	of	irrevers-
ible erros.16 Some studies have evaluated the immunoexpression of 
these	proteins	in	the	degrees	of	dysplasia	that	AC	may	present,	as	
well	as	in	cancer,	but	no	study	has	correlated	the	immunoexpression	
Table 1: hMLH1 and hMSH2 immunoexpression in epidemiological and clinical characteristics of actinic cheilits
VARIABLE  n  IMMUNOEXPRESSION
   hMLH1  hMSH2
   mean+SD(a) p(b) mean+SD(a) p(b)
Gender	 Male	 30	 640,93+163,13	 0.338	 714,47+187,97	 0.658
	 Female	 10	 698,40+159,41	 	 744,10+161,68	      
Age	range	 ≥	40	years	 32	 655,53+171,09	 0.986	 728,16+177,48	 0.665
	 <	40	years	 8	 654,38+129,67	 	 696,75+201,33	      
Ethnicity*	 White	 26	 659,73+150,14	 0.459	 711,69+190,78	 0.371
	 Mixed-race/black	 9	 705,00+173,88	 	 775,67+153,49	      
Clinical	aspect*	 White	lesion	 20	 706,75+139,74	 0.166	 753,00+163,34	 0.615
	 Red	lesion	 14	 634,07+157,32	 	 720,57+209,11	
      
Occupational	sunlight	exposure*	 Yes	 24	 663,88+142,09	 0.372	 702,58+202,60	 0.524
	 No	 11	 712,36+159,97	 	 746,64+149,09	
Legends: SD - standard deviation;  *The variables have missing data; (a): The data presented comprise the number of positive cells per 1,000 lesional 
cells;  (b): T-student test.
FIgure 1: 
Immunoexpression of 
hMLH1 and hMSH2 in ac-
tinic	 cheilitis	 (AC).	 (a)	 Im-
munostaining of hMLH1 
in	AC	with	mild	dysplasia	
(arrow).	 Patient	 present-
ed white lesion in lower 
lip;	 (b)	 Immunoexpression	
of	 hMLH1	 protein	 in	 AC	
with moderate dysplasia 
(arrow).	 Patient	 present-
ed white and red lesion in 
lower	 lip;	 (c)	 Immunoex-
pression of hMSH2 protein 
in	 AC	 without	 dysplasia	
(arrow).	 Patient	 present-
ed white lesion in lower 
lip;	 (d)	 Immunostaining	
of	 hMSH2	 protein	 in	 AC	
with moderate dysplasia 
(arrow).	 Patient	 presented	
white lesion in lower lip. 
(ADVANCE,	HRP-400x)
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of	 these	proteins	with	epidemiological	and	clinical	aspects	 in	AC.	
5,6,8,17-19		This	study	is	the	first	in	the	literature	to	analyze	differences	
in	 expression	of	hMLH1	and	hMSH2	proteins,	 correlating	 it	with	
epidemiological	and	clinical	characteristics	of	AC.
Regarding the immunoexpression of hMLH1 and hMSH2 
proteins	and	its	association	with	clinical	parameters,	we	found	that	
females showed greater immunoexpression of both proteins evalu-
ated.	We	believe	that	this	is	due	to	women’s	use	of	lipstick,	which	
prevents damage caused by ultraviolet radiation. The protective ac-
tion	of	lipstick	has	been	reported	by	other	studies.2,20
The immunoexpression of hMLH1 was identical across 
the	various	age	groups.	For	the	hMSH2	protein,	people	aged	over	
40 presented higher levels of immunoexpression. Fernandes et 
al.18 evaluated oral mucosa while Caldeira et al.5 analyzed	oral	leuko-
plakia,	uncovering	no	association	between	sex/age	and	the	expres-
sion	of	these	proteins.	Additionally,	the	authors	reported	that	lesion	
sites	 do	 not	 influence	 immunoexpression.	 Helal	 et al.21 examined 
oral	 squamous	 cell	 carcinoma	and	oral	dysplastic	 lesions,	finding	
no	significant	differences	 in	 the	 immunoexpression	of	hMSH2	for	
the variables of sex and age.
Regarding	 ethnicity,	 we	 observed	 in	 our	 study	 a	 higher	
immunoexpression	of	the	proteins	in	the	mixed-race/black	group.	
Skin	 type	 is	 an	 important	 factor	 in	AC;	 patients	with	white	 skin	
have	a	higher	likelihood	of	developing	AC.	The	protective	effects	of	
melanin	in	natural	skin	against	the	carcinogenic	action	of	ultraviolet	
radiation can explain the higher immunoexpression of hMLH1 and 
hMSH2	in	black	and	mixed-race	individuals.1,2,22
Immunohistochemical staining of hMLH1 and hMSH2 
proteins is negative when the genes that encode them are mutat-
ed.	Therefore,	 a	 reduction	 in	 immunoexpression	of	 these	proteins	
is regarded as related to the development of premalignant and ma-
lignant lesions.5-8,17,18	This	explains	why	the	profiles	of	women	aged	
over	40	and	of	mixed-race	and	black	individuals	involve	greater	im-
munoexpression	of	hMLH1	and	hMSH2	proteins,	confirming	that	
these groups undergo fewer mutations in these genes and experi-
ence	a	lower	risk	of	malignant	transformation.
In	assessing	the	clinical	aspect,	white	lesions	showed	great-
er immunoexpression for proteins compared with red lesions. Giv-
en	the	results,	we	believe	that	red	lesions	exhibit	more	aggressive	
behavior	 than	white	 lesions.	 In	 the	 literature,	 the	 relationship	be-
tween	red	lesions	and	more	severe	dysplasia	or	squamous	cell	carci-
noma	is	well	recognized.1,10,20,23,24
Moreover,	 we	 found	 that	 people	 who	 performed	 profes-
sional	 activities	 without	 sun	 exposure,	 possessed	 greater	 immu-
noexpression	 of	 both	 hMLH1	 and	 hMHS2	 proteins	 than	workers	
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exposed	to	sunlight.	This	result	confirms	the	damage	in	the	MMR	
system caused by ultraviolet exposure.3,4,15	The promotion or activa-
tion	of	hMSH2	expression	may	be	induced	by	the	increased	DNA	
damage	due	to	sun	exposure.	Further,	the	expression	decreases	with	
the	severity	of	the	lesion,	from	precancerous	lesions	to	scamous	cell	
carcinoma.25
This study aimed to assess whether the immunoexpression 
of hMLH1 and hMSH2 proteins bore a relationship with clinical 
variables	in	AC.	Despite	the	differences	noted	regarding	the	immu-
noexpression	of	these	proteins	in	the	variables,	no	significant	statis-
tical differences were observed. Fernandes et al.18 reported that these 
results	may	reflect	 the	primitive	function	and	basic	MMR	system,	
as conserved throughout evolution and unchanged in demographic 
changes.
This paper presents data suggesting that clinical charac-
teristics are involved in changing the immunoexpression of these 
proteins.	AC	is	a	lesion	with	malignant	potential	and	entailing	pro-
gression	 to	squamous	cell	 carcinoma	of	 the	 lips.	The	hMLH1	and	
hMSH2 proteins are actively involved in the carcinogenesis process 
of	 this	 lesion,	since	 immunoexpression	decreases	as	 the	 lesion	be-
comes more severe.5-8,17,18	It is normal to uncover a high expression 
of these proteins in normal patients.18 Lower immunoexpression of 
hMLH1	and	hMSH2	was	noted	in	white	males	aged	under	40.	AC	
with a red appearance and patients with occupational sunlight ex-
posure also presented lower immunoexpression of these proteins. 
The decreased immunoexpression of the proteins studied is directly 
related	to	the	risk	of	cancer.7,19,21	Hence,	 the	aforementioned	group	
can	be	characterized	as	a	higher-risk	group	for	progression	of	AC	to	
squamous	cell	carcinoma	of	the	lips.
For	 dermatologists,	 this	 study	 enhances	 understanding	
of	the	pathogenesis	of	AC,	as	well	as	the	behavior	of	these	lesions	
in	patients	with	clinical	differences.	The	survey	also	identified	the	
highest-risk	group	for	developing	premalignant	and	malignant	le-
sions,	whilst	outlining	the	lower-risk	group,	both	related	to	the	im-
munosuppression	of	hMLH1	and	hMSH2	proteins,	which	is	clearly	
linked	to	cancer	progression.
CONCLUSION
In	summary,	the	results	of	this	study	showed	variations	in	
the	immunoexpression	of	hMLH1	and	hMSH2	proteins,	as	reflected	
in	the	evaluation	of	epidemiological	and	clinical	AC	characteristics.	
Despite	 the	differences	 observed,	 further	 studies	 are	necessary	 to	
confirm	these	trends.q
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